Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study -- Pullarkat et al. 111 (5): 2563 Data Supplement - <font size="3">Supplemental materials for: Pullarkat et al</font> -- Blood

Blood, Vol. 111, Issue 5, 2563-2572, March 1, 2008

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study
Blood Pullarkat et al. 111: 2563

Supplemental materials for: Pullarkat et al

Files in this Data Supplement:

Table S1 (PDF, 30 KB) -
(A) Summary of univariate logistic regression models of complete response (CR) rate among 200 adult patients with previously untreated non-L3 ALL. (B) Details of selected multivariate logistic regression models for complete response (CR) rate, based on 140 adult patients with previously untreated non L3 ALL and evaluable cytogenetics.
Table S2 (PDF, 40.6 KB) -
(A) Summary of univariate proportional hazards regression models of overall survival among 200 adult patients with previously untreated non-L3 ALL. (B) Details of selected multivariate proportional hazards regression models for overall survival (OS), based on 140 adult patients with previously untreated non L3 ALL and evaluable cytogenetics. (C) Details of selected multivariate proportional hazards regression models for overall survival (OS), based on 104 adult patients with previously untreated non L3 ALL and evaluable cytogenetics, and without t(9;22)/BCR/ABL1.
Table S3 (PDF, 31 KB) -
(A) Summary of univariate proportional hazards regression models of relapse-free survival among 159 adult patients with previously untreated non-L3 ALL who achieved complete response. (B) Details of selected multivariate proportional hazards regression models for relapse free survival (RFS), based on 110 adult patients with previously untreated non L3 ALL and evaluable cytogenetics who achieved complete response.
Table S4 (PDF, 37.2 KB) -
(A) Summary of univariate proportional hazards regression models of disease-free survival among 83 adult patients with previously untreated non-L3 ALL who achieved complete response and received maintenance chemotherapy. (B) Details of selected multivariate proportional hazards regression models for disease free survival (DFS), based on 55 adult patients with previously untreated non L3 ALL and evaluable cytogenetics who achieved complete response and received protocol maintenance chemotherapy.
Table S5. Institutions and PIs registering eligible patients to S9400 (PDF, 16.9 KB)